open-angle glaucoma

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instance_of gptkb:sneaker
gptkbp:bfsLayer 7
gptkbp:bfsParent gptkb:Vyzulta
gptkb:latanoprost
gptkbp:affects optic nerve
gptkbp:can_lead_to blindness
gptkbp:caused_by vision loss
irreversible blindness
gptkbp:focuses_on patient education
public health initiatives
clinical research
https://www.w3.org/2000/01/rdf-schema#label open-angle glaucoma
gptkbp:is_associated_with inflammation
family history
visual impairment
retinal nerve fiber layer thinning
trabecular meshwork dysfunction
gptkbp:is_characterized_by increased intraocular pressure
gptkbp:is_considered_as early stages
gptkbp:is_influenced_by gptkb:Company
ethnicity
high blood pressure
myopia
gptkbp:is_monitored_by regular eye exams
gptkbp:is_often_depicted_as angle-closure glaucoma
gptkbp:is_often_used_in older adults
gptkbp:is_studied_in ophthalmology
gptkbp:managed_by gptkb:stadium
stress reduction
lifestyle changes
dietary modifications
gptkbp:recognizes visual field tests
optical coherence tomography
tonometry
gptkbp:requires lifetime management
gptkbp:scientific_classification gptkb:psychologist
eye diseases
primary open-angle glaucoma
secondary open-angle glaucoma
gptkbp:social_responsibility eye examination
gptkbp:subject gptkb:municipality
awareness campaigns
treatment protocols
screening recommendations
gptkbp:symptoms peripheral vision loss
tunnel vision
gptkbp:treatment gptkb:hospital
medications
laser therapy
beta-blockers
prostaglandin analogs
carbonic anhydrase inhibitors
Rho kinase inhibitors
alpha agonists
gptkbp:type_of chronic glaucoma